Stocks and Investing
Stocks and Investing
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Hartaj Singh Maintained (ATXS) at Buy with Increased Target to $29 on, Mar 26th, 2024
Hartaj Singh of Oppenheimer, Maintained "Astria Therapeutics, Inc." (ATXS) at Buy with Increased Target from $25 to $29 on, Mar 26th, 2024.
Hartaj has made no other calls on ATXS in the last 4 months.
There are 2 other peers that have a rating on ATXS. Out of the 2 peers that are also analyzing ATXS, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Hartaj
- Eun Yang of "Jefferies" Maintained at Strong Buy with Increased Target to $27 on, Monday, March 25th, 2024
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $18 on, Monday, March 25th, 2024
Contributing Sources